Advertisement

Topics

Oxford Therapeutics Consulting Limited Company Profile

15:52 EDT 20th September 2017 | BioPortfolio

Consulting for the phatmaceutical and drug development.

Location

The Magdalen Centre
Oxford
Oxfordshire
OX4 4GA
United Kingdom

Contact

Phone: +44 1865 784874
Fax: +44 1865 784875
Email: jansteiner@oxrx.xom


News Articles [2097 Associated News Articles listed on BioPortfolio]

Oxford Synbio Startup with Eyes on Therapeutics gets hold of CRISPR

Synbio startup Oxford Genetics has licensed CRISPR from Emmanuelle Charpentier’s company, ERS Genomics, to boost its platform. Synthetic biology has so far remained on the fringe of biotech, but...

Oxford BioMedica in Second CART Deal with Novartis

UK biopharma Oxford BioMedica has signed another major deal with Swiss drugmaker Novartis to supply lentiviral vectors used to create novel cell therapeutics, including CTL019 (tisagenlecleucel) and o...

New light on the secret life of badgers

(University of Oxford) Badgers are more sociable than often thought, with implications for how they transmit disease, new Oxford University research reveals. Using security tracking technology more co...

Open Therapeutics and AuthorAID to Cooperate on Advancing Scientific Knowledge

Minneapolis, MN and Oxford, UK (PRWEB) June 02, 2017 Open Therapeutics and INASP’s AuthorAID project announce the formation of ...

#jobs #lifescience Immunocore: Early Diagnostic Senior Scientist – Oxford

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Immunocore: Early Diagnostic Senior Scientist – Oxford . Competitive sa...

Oxford Genetics Secures ??7.5 Million Investment

21st August 2017, Oxford Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has announced a 7.5 million investment into it...

Summit Therapeutics to Report Financial Results for the Second Quarter and Half Year Ended 31 ...

OXFORD, United Kingdom, Aug. 25, 2017 (GLOBE NEWSWIRE) Read more...

Silence Therapeutics boss appointed non-exec chairman of University of Oxford spin-out

Ali Mortazavi, the boss of gene silencing specialist Silence Therapeutics PLC (LON:SLN), has been appointed as the non-executive chairman of artificial intelligence and healthcare firm, Ultromics. U...

PubMed Articles [1219 Associated PubMed Articles listed on BioPortfolio]

Book Reviews Pharmacology and Therapeutics of Asthma and COPD Edited by Clive P Page , Peter J Barnes Springer 2017 Price £278.50. Pp 285 ISBN 978 3 319 52173 2 Oxford Handbook of Infectious Diseases and Microbiology ( 2nd edn ) Estee Torok , Ed Moran , Fiona Cooke Oxford University Press 2016 Price £34.99. Pp 879 ISBN 978 0 19 9671328 Anaesthesia for the Elderly Patient ( 2nd edn ) Chris Dodds

The effects of implementing a point-of-care electronic template to prompt routine anxiety and depression screening in patients consulting for osteoarthritis (the Primary Care Osteoarthritis Trial): A cluster randomised trial in primary care.

This study aimed to evaluate whether prompting general practitioners (GPs) to routinely assess and manage anxiety and depression in patients consulting with osteoarthritis (OA) improves pain outcomes.

The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.

The Oxford Classification for Immunoglobulin A nephropathy (IgAN) identifies pathological variables that may predict the decline of renal function. This study aimed to evaluate the Oxford Classificati...

Are Expectations for Community Mental Health Increasing Among Older Adults in China?

In recent years, the Chinese government began expanding access to social services to older adults. This study examined whether older adults have increasing expectations that psychological consulting s...

Consulting on surveillance.

Clinical Trials [225 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

A Clinical Investigation of the Oxford® Partial Knee System

The purpose of this prospective data collection is to document the performance and clinical outcomes of the Oxford® Partial Knee System.

Companies [2345 Associated Companies listed on BioPortfolio]

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

Oxford Therapeutics Consulting Limited

Consulting for the phatmaceutical and drug development.

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

Isis Innovation

Isis Innovation is the technology transfer company of the University of Oxford, commercialising the research generated by University researchers and owned by the University.Isis Innovation Ltd is a wh...

Accelrys, Inc

The software businesses of the Oxford Molecular Group were incorporated into Accelrys Inc. on June 1, 2001.Oxford Molecular was a leading provider of cheminformatics tools. Founded in 1989, Oxford Mol...

More Information about "Oxford Therapeutics Consulting Limited" on BioPortfolio

We have published hundreds of Oxford Therapeutics Consulting Limited news stories on BioPortfolio along with dozens of Oxford Therapeutics Consulting Limited Clinical Trials and PubMed Articles about Oxford Therapeutics Consulting Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Therapeutics Consulting Limited Companies in our database. You can also find out about relevant Oxford Therapeutics Consulting Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record